期刊文献+

醛固酮瘤中醛固酮合成相关酶与相应调节基因表达的变化

Expression of aldosterone synthesis related enzyme and associated regulatory factor genes in aldosterone-producing adenoma
下载PDF
导出
摘要 目的比较醛固酮瘤(APA)与正常肾上腺组织的基因表达谱,探讨醛固酮合成过程的差异与可能的调节异常。方法以术后病理学检查确诊为APA的组织标本(APA组,n=10)及正常肾上腺组织(对照组,n=7)作为研究对象。提取两种组织的总RNA,合成生物素标记的探针cRNA,与载有一组靶基因的基因表达谱芯片杂交;通过扫描荧光强度,计算机软件分析,得到两种组织的表达差异基因;对异常表达靶基因进行Real-time PCR验证。结果与对照组相比,APA组有97个基因表达上调,168个基因表达下调;醛固酮合成路径中,仅CYP11B2表达显著上调;生理性调节醛固酮合成的因子中,CYB5A、CYP17A1、DUSP1、HMGCR表达下调,RENBP和NR1H2表达上调;皮质醇合成关键酶CYP17A1表达被抑制。结论在APA的醛固酮合成路径相关酶与调节因子中,CYP11B2可能是关键合成酶;多数生理性调节因子被抑制,提示存在肿瘤性调节因素。 Objective To investigate the discrepancy of aldosterone synthesis process and potential regulation abnormality between aldosterone-producing adenoma (APA) and normal adrenal (NA) with microarray. Methods cRNA probes labelled with biotin were prepared from mRNA of APAs (APA group, n = 10) or NAs (control group, n = 7). The probes were hybridized with oligonucleotide microarray of target gene expression profile. Expression levels were read from the fluorescent intensity scanned. The difference of gene expression profile was analyzed by computer software. Differentially expressed genes were verified by real-time RT-PCR. Results Compared with control group, 97 genes were up-regulated and 168 genes were down-regulated in APA group. In the genes related to steroid hormone synthesis, only CYPllB2 was significantly up-regulated. In the physiologic regulators of aldosterone synthesis, CYBSA, CYP17A1, DUSP1 and HMGCR were down-regulated, while RENBP and NR1H2 were up-regulated. As a key enzyme in the biosynthesis of cortisol, the expression of CYP17A1 gene was inhibited. Conclusion Among the aldosterone synthesis related enzyme and corresponding regulatory genes in APA, CYP11B2 may be a key synthetase, and the suppressed physiologic regulators of aldosterone synthesis may indicate the existence of neoplastic modulation.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第8期959-962,966,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 基因芯片 醛固酮瘤 醛固酮合成酶 调节因子 microarray aldosterone-producing adenoma aldosterone synthetase regulatory factor
  • 相关文献

参考文献15

  • 1Moo TA, Zarnegar R, Duh QY. Prediction of successful outcome in patients with primary aldosteronism [ J ]. Curt Treat Options Oncol, 2007,8 (4) :314 -321.
  • 2Calhoun DA. Aldosteronism and hypertension [ J ]. Clin J Am Soc Nephrol ,2006,1( 5 ) : 1039 - 1045.
  • 3杨洋,汤正义,张炜,吴景程,王卫庆,李小英,宁光.原发性醛固酮增多症的药物治疗现状[J].世界临床药物,2006,27(11):657-660. 被引量:4
  • 4吴景程,汤正义,张炜,凌丹芸,侯瑞芳,王卫庆,李小英,宁光.单侧肾上腺结节增生性原发性醛固酮增多症的临床特点和随访结果分析[J].中华医学杂志,2006,86(46):3302-3305. 被引量:9
  • 5Enberg U,Farnebo LO,Wedell A,et al. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17 [J]. World J Surg,2001,25(7) :957 -966.
  • 6Zenkert S, Schubert B, Fassnacht M, et al. Steroidogenic acute regulatory protein mRNA expression in adrenal tumours [ J]. Eur J Endocrinol,2000,142 ( 3 ) :294 - 299.
  • 7Bird IM, Pasquarette MM, Rainey WE, et al. Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells[ J]. J Clin Endocrinol Metab, 1996,81(6) :2171 -2178.
  • 8Pandey AV, Miller WL. Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17 [ J]. J Biol Chem ,2005,280(14) : 13265 - 13271.
  • 9Sewer MB, Waterman MR. cAMP-dependent protein kinase enhances CYP17 transcription via MKP-1 activation in H295R human adrenocortical cells[ J]. J Biol Chem,2003,278 (10) :8106 - 8111.
  • 10Romero DG, Plonczynski MW, Gomez-Sanchez EP, et al. RGS2 is regulated by angiotensin Ⅱ and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells [ J].Endocrinology ,2006,147 ( 8 ) :3889 - 3897.

二级参考文献18

  • 1吴景程,汤正义,张炜,侯瑞芳,凌丹芸,李小英,王卫庆,宁光.原发性醛固酮增多症患者心血管和肾功能指标的改变[J].上海交通大学学报(医学版),2006,26(1):48-50. 被引量:11
  • 2张炜,汤正义,王卫庆,吴景程,张华,宁光.肾上腺静脉采血在原发性醛固酮增多症分型诊断中的应用[J].中华内分泌代谢杂志,2006,22(5):411-413. 被引量:16
  • 3曾正陪.醛固酮增多症.见:"史轶蘩,主编.协和内分泌和代谢学.北京:科学出版社,1999.1184-1187
  • 4Mulatero P,Stowasser M,Keh-Chuan Loh,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents.J Clin Endocrinol Metab,2004,89:1045-1050.
  • 5Ganguly A,Zager PG,Luetscher JA.Primary aldosteronism due to unilateral adrenal hyperplasia.J Clin Endocrinol Metab,1980,51:1190-1194.
  • 6Pignatelli D,Falcao H,Coimbra-Peixoto A,et al.Unilateral adrenal hyperplasia.South Med J,1994,87:664-667.
  • 7Morioka M,Kobayashi T,Sone A,et al.Primary aldosteronism due to unilateral adrenal hyperplasia:report of two cases and review of the literature.Endocr J,2000,47:443-449.
  • 8Katayama Y,Takata N,Tamura T,et al.A case of primary aldosteronism due to unilateral adrenal hyperplasia.Hypertens Res,2005,28:379-384.
  • 9Hirono Y,Doi M,Yoshimoto T,et al.A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules.Endocr J,2005,52:435-439.
  • 10Novisky YW,Kercher KW,Rosen MJ,et al.Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia.Surgery,2005,138:1009-1016.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部